Trader James Riley, center, works on the floor of the New York Stock Exchange, Tuesday, April 8, 2014. Stocks were mixed in early trading on Tuesday after a three-day slump. Investors will start to focus on company earnings this week. (AP Photo/Richard Drew)
April 08, 2014 - 6:28 AM
NEW YORK, N.Y. - Stock futures were little changed on Tuesday, suggesting that a three-day slump in the market may abate. Investors will also start to focus on company earnings this week.
KEEPING SCORE: In pre-market trading, the Dow Jones industrial average futures slipped five points, which meant they were little changed at 16,173 as of 9:15 a.m. (1315 GMT). Standard & Poor's 500 index futures were unchanged at 1,838. Nasdaq futures rose seven points, or 0.2 per cent, to 3,506.
THE SLUMP: The market logged its longest losing streak in two months Monday, extending a sell-off that began last week. A slump that started in technology and biotechnology stocks spread to companies that sell non-essential goods and services.
DRUG TROUBLE: Eli Lilly fell 63 cents, or 1.1 per cent, to $57.99 before the market opened. The stock declined after a U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly, to pay $9 billion in punitive damages over a diabetes medicine linked to cancer.
BONDS AND COMMODITIES: In government bond trading, the yield on the 10-year Treasury note edged up to 2.71 per cent from 2.70 per cent late Monday. The price of crude oil rose 78 cents to $101.22 a barrel. Gold rose $13.20, or 1 per cent, to $1,311.70 an ounce
News from © The Associated Press, 2014